Enanta Pharmaceuticals
ENTA
#7992
Rank
C$0.55 B
Marketcap
C$19.25
Share price
0.29%
Change (1 day)
115.72%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -C$70.94 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$69.21 Million. In 2025 the company made an earning of -C$89.17 Million, an increase over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$70.94 Million-20.44%
2025 -C$89.17 Million-34.07%
2024 -C$0.14 Billion-23.87%
2023 -C$0.18 Billion4.39%
2022 -C$0.18 Billion-4.4%
2021 -C$0.18 Billion91.12%
2020 -C$93.15 Million-407.13%
2019 C$30.32 M-78.63%
2018 C$0.14 B117.97%
2017 C$65.11 M-574.65%
2016 -C$13.72 Million-110.83%
2015 C$0.12 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$24.64 Million-137.98%
2012 C$64.86 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.21 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.00 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
C$8.33 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$7.05 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.33 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.38 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA